These can include adherence to medication, lifestyle modifications, individual metabolism, underlying medical conditions, dietary patterns, and exercise habits
2023;278(4):e7605
What is clear from published phase 2 data is that diarrhoea is among the most commonly reported adverse effects, particularly during the early weeks of treatment and following each dose increase
Coverage for GLP-1 medications varies across all of these, and Anthems policies have been evolving as these medications have become more prominent
Hepcidin, a circulating peptide hormone produced in the liver, is the key regulator of both iron absorption and distribution throughout the body [2][5]
Beyond weight numbers, clinical data reveal improvements in cardiometabolic markers including fasting glucose, cholesterol profiles, and blood pressurebenefits that extend therapy beyond appearance to cardiovascular health